RHY logo

Rhythm Biosciences Limited Stock Price

ASX:RHY Community·AU$27.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RHY Share Price Performance

AU$0.085
-0.05 (-37.04%)
AU$0.085
-0.05 (-37.04%)
Price AU$0.085

RHY Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
1 Reward

Rhythm Biosciences Limited Key Details

AU$3.2m

Revenue

AU$224.9k

Cost of Revenue

AU$3.0m

Gross Profit

AU$6.8m

Other Expenses

-AU$3.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.012
92.95%
-119.97%
151.5%
View Full Analysis

About RHY

Founded
2017
Employees
n/a
CEO
David Atkins
WebsiteView website
rhythmbio.com

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Recent RHY News & Updates

Recent updates

No updates